RABEPRAZOLE for Secondary progressive multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 86 adverse event reports in the FDA FAERS database where RABEPRAZOLE was used for Secondary progressive multiple sclerosis.
Most Reported Side Effects for RABEPRAZOLE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Chronic kidney disease | 4,773 | 41.8% | 809 | 253 |
| Renal failure | 3,135 | 27.5% | 948 | 199 |
| Acute kidney injury | 2,545 | 22.3% | 601 | 260 |
| End stage renal disease | 1,295 | 11.3% | 439 | 102 |
| Tubulointerstitial nephritis | 1,125 | 9.9% | 323 | 105 |
| Death | 857 | 7.5% | 854 | 21 |
| Drug ineffective | 732 | 6.4% | 2 | 218 |
| Dyspnoea | 423 | 3.7% | 3 | 232 |
| Gastrooesophageal reflux disease | 416 | 3.6% | 29 | 56 |
| Headache | 387 | 3.4% | 13 | 79 |
| Cough | 382 | 3.4% | 2 | 180 |
| Off label use | 360 | 3.2% | 2 | 67 |
| Renal injury | 343 | 3.0% | 41 | 52 |
| Drug intolerance | 329 | 2.9% | 0 | 53 |
| Diarrhoea | 317 | 2.8% | 17 | 106 |
Other Indications for RABEPRAZOLE
Product used for unknown indication (4,607)
Gastrooesophageal reflux disease (1,689)
Helicobacter infection (327)
Migraine (161)
Dyspepsia (120)
Prophylaxis (103)
Prophylaxis against gastrointestinal ulcer (103)
Gastric ulcer (69)
Gastritis (61)
Oesophagitis (48)
Other Drugs Used for Secondary progressive multiple sclerosis
SIPONIMOD (2,265)
OCRELIZUMAB (1,273)
OFATUMUMAB (1,099)
FINGOLIMOD (351)
INTERFERON BETA-1B (146)
RITUXIMAB (131)
NATALIZUMAB (115)
DIMETHYL (96)
INTERFERON BETA-1A (89)
DALFAMPRIDINE (85)